XML 27 R67.htm IDEA: XBRL DOCUMENT v2.4.0.6
(LOSS) EARNINGS PER SHARE (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
(LOSS) EARNINGS PER SHARE    
Net (loss) income $ (12,921) $ 6,482
Basic weighted-average number of common shares outstanding (000s) 307,776 303,749
Dilutive effect of stock options and RSUs (000s) (in shares)   8,427
Dilutive effect of convertible notes (000s) (in shares)   20,724
Diluted weighted-average number of common shares outstanding (000s) 307,776 332,900
Earnings (loss) per share attributable to Valeant Pharmaceuticals International, Inc.    
Basic and diluted (loss) earnings per share $ (0.04) $ 0.02